Mouse models and aging: Longevity and progeria

Current Topics in Developmental Biology

Volumn 109, Issue , 2014, Pages 249-285

  Liao, Chen Yu ^a   Kennedy, Brian K ^a  

^a BUCK INSTITUTE FOR RESEARCH ON AGING   (United States)

Author keywords

Lifespan; Longevity; Mouse models; Progeria

Indexed keywords

SIRTUIN;

AGING; ANIMAL; ANIMAL MODEL; BIOLOGICAL MODEL; CARCINOGENESIS; DNA REPAIR; GENETICS; GENOMIC INSTABILITY; LONGEVITY; METABOLISM; MOUSE; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHYSIOLOGY; PROGERIA; SIGNAL TRANSDUCTION;

AGING; ANIMALS; CARCINOGENESIS; DNA REPAIR; GENOMIC INSTABILITY; LONGEVITY; MICE; MODELS, ANIMAL; MODELS, GENETIC; OXIDATIVE STRESS; PROGERIA; SIGNAL TRANSDUCTION; SIRTUINS;

EID: 84902489942     PISSN: 00702153     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-397920-9.00003-2     Document Type: Chapter

References (205)

1. Agarwal B., Baur J.A. Resveratrol and life extension. Annals of the New York Academy of Sciences 2011, 1215:138-143.
2. Alayev A., Holz M.K. mTOR signaling for biological control and cancer. Journal of Cellular Physiology 2013, 228:1658-1664.
3. Andersen J.K. Oxidative stress in neurodegeneration: Cause or consequence?. Nature Medicine 2004, 10(Suppl.):S18-S25.
4. Anisimov V.N., Berstein L.M., Egormin P.A., Piskunova T.S., Popovich I.G., Zabezhinski M.A., et al. Effect of metformin on life span and on the development of spontaneous mammary tumors in HER-2/neu transgenic mice. Experimental Gerontology 2005, 40:685-693.
5. Anisimov V.N., Egormin P.A., Piskunova T.S., Popovich I.G., Tyndyk M.L., Yurova M.N., et al. Metformin extends life span of HER-2/neu transgenic mice and in combination with melatonin inhibits growth of transplantable tumors in vivo. Cell Cycle 2010, 9:188-197.
6. Anisimov V.N., Zabezhinski M.A., Popovich I.G., Piskunova T.S., Semenchenko A.V., Tyndyk M.L., et al. Rapamycin extends maximal lifespan in cancer-prone mice. The American Journal of Pathology 2010, 176:2092-2097.
7. Anisimov V.N., Zabezhinski M.A., Popovich I.G., Piskunova T.S., Semenchenko A.V., Tyndyk M.L., et al. Rapamycin increases lifespan and inhibits spontaneous tumorigenesis in inbred female mice. Cell Cycle 2011, 10:4230-4236.
8. Arimura T., Helbling-Leclerc A., Massart C., Varnous S., Niel F., Lacene E., et al. Mouse model carrying H222P-Lmna mutation develops muscular dystrophy and dilated cardiomyopathy similar to human striated muscle laminopathies. Human Molecular Genetics 2005, 14:155-169.
9. Baker D.J., Jeganathan K.B., Cameron J.D., Thompson M., Juneja S., Kopecka A., et al. BubR1 insufficiency causes early onset of aging-associated phenotypes and infertility in mice. Nature Genetics 2004, 36:744-749.
10. Baker D.J., Wijshake T., Tchkonia T., LeBrasseur N.K., Childs B.G., van de Sluis B., et al. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 2011, 479:232-236.
11. Baker D.J., Dawlaty M.M., Wijshake T., Jeganathan K.B., Malureanu L., van Ree J.H., et al. Increased expression of BubR1 protects against aneuploidy and cancer and extends healthy lifespan. Nature Cell Biology 2013, 15:96-102.
12. Bartke A. Can growth hormone (GH) accelerate aging? Evidence from GH-transgenic mice. Neuroendocrinology 2003, 78:210-216.
13. Bartke A., Sun L.Y., Longo V. Somatotropic signaling: Trade-offs between growth, reproductive development, and longevity. Physiological Reviews 2013, 93:571-598.
14. Barzilai N., Huffman D.M., Muzumdar R.H., Bartke A. The critical role of metabolic pathways in aging. Diabetes 2012, 61:1315-1322.
15. Baur J.A. Resveratrol, sirtuins, and the promise of a DR mimetic. Mechanisms of Ageing and Development 2010, 131:261-269.
16. Baur J.A., Sinclair D.A. Therapeutic potential of resveratrol: The in vivo evidence. Nature Reviews Drug Discovery 2006, 5:493-506.
17. Benigni A., Corna D., Zoja C., Sonzogni A., Latini R., Salio M., et al. Disruption of the Ang II type 1 receptor promotes longevity in mice. The Journal of Clinical Investigation 2009, 119:524-530.
18. Bergo M.O., Gavino B., Ross J., Schmidt W.K., Hong C., Kendall L.V., et al. Zmpste24 deficiency in mice causes spontaneous bone fractures, muscle weakness, and a prelamin A processing defect. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:13049-13054.
19. Bluher M., Kahn B.B., Kahn C.R. Extended longevity in mice lacking the insulin receptor in adipose tissue. Science 2003, 299:572-574.
20. Bluher M., Michael M.D., Peroni O.D., Ueki K., Carter N., Kahn B.B., et al. Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance. Developmental Cell 2002, 3:25-38.
21. Boily G., Seifert E.L., Bevilacqua L., He X.H., Sabourin G., Estey C., et al. SirT1 regulates energy metabolism and response to caloric restriction in mice. PLoS One 2008, 3:e1759.
22. Bokov A.F., Garg N., Ikeno Y., Thakur S., Musi N., DeFronzo R.A., et al. Does reduced IGF-1R signaling in Igf1r+/- mice alter aging?. PLoS One 2011, 6:e26891.
23. Bonkowski M.S., Rocha J.S., Masternak M.M., Al Regaiey K.A., Bartke A. Targeted disruption of growth hormone receptor interferes with the beneficial actions of calorie restriction. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:7901-7905.
24. Bordone L., Cohen D., Robinson A., Motta M.C., van Veen E., Czopik A., et al. SIRT1 transgenic mice show phenotypes resembling calorie restriction. Aging Cell 2007, 6:759-767.
25. Brown-Borg H.M., Borg K.E., Meliska C.J., Bartke A. Dwarf mice and the ageing process. Nature 1996, 384:33.
26. Burtner C.R., Kennedy B.K. Progeria syndromes and ageing: What is the connection? Nature reviews. Molecular Cell. Biology 2010, 11:567-578.
27. Cao K., Blair C.D., Faddah D.A., Kieckhaefer J.E., Olive M., Erdos M.R., et al. Progerin and telomere dysfunction collaborate to trigger cellular senescence in normal human fibroblasts. The Journal of Clinical Investigation 2011, 121:2833-2844.
28. Cao K., Graziotto J.J., Blair C.D., Mazzulli J.R., Erdos M.R., Krainc D., et al. Rapamycin reverses cellular phenotypes and enhances mutant protein clearance in Hutchinson-Gilford progeria syndrome cells. Science Translational Medicine 2011, 3. 89ra58.
29. Casellas J., Medrano J.F. Lack of Socs2 expression reduces lifespan in high-growth mice. Age 2008, 30:245-249.
30. Ceylan-Isik A.F., Dong M., Zhang Y., Dong F., Turdi S., Nair S., et al. Cardiomyocyte-specific deletion of endothelin receptor A rescues aging-associated cardiac hypertrophy and contractile dysfunction: Role of autophagy. Basic Research in Cardiology 2013, 108:335.
31. Chang H.C., Guarente L. SIRT1 and other sirtuins in metabolism. Trends in Endocrinology and Metabolism 2014, 25:138-145.
32. Chang S., Multani A.S., Cabrera N.G., Naylor M.L., Laud P., Lombard D., et al. Essential role of limiting telomeres in the pathogenesis of Werner syndrome. Nature Genetics 2004, 36:877-882.
33. Chiu C.H., Lin W.D., Huang S.Y., Lee Y.H. Effect of a C/EBP gene replacement on mitochondrial biogenesis in fat cells. Genes & Development 2004, 18:1970-1975.
34. Colman R.J., Anderson R.M., Johnson S.C., Kastman E.K., Kosmatka K.J., Beasley T.M., et al. Caloric restriction delays disease onset and mortality in rhesus monkeys. Science 2009, 325:201-204.
35. Conover C.A., Bale L.K. Loss of pregnancy-associated plasma protein A extends lifespan in mice. Aging Cell 2007, 6:727-729.
36. Conover C.A., Bale L.K., Grell J.A., Mader J.R., Mason M.A. Longevity is not influenced by prenatal programming of body size. Aging Cell 2010, 9:647-649.
37. Conover C.A., Bale L.K., Mader J.R., Mason M.A., Keenan K.P., Marler R.J. Longevity and age-related pathology of mice deficient in pregnancy-associated plasma protein-A. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 2010, 65:590-599.
38. Conti B., Sanchez-Alavez M., Winsky-Sommerer R., Morale M.C., Lucero J., Brownell S., et al. Transgenic mice with a reduced core body temperature have an increased life span. Science 2006, 314:825-828.
39. Coschigano K.T., Clemmons D., Bellush L.L., Kopchick J.J. Assessment of growth parameters and life span of GHR/BP gene-disrupted mice. Endocrinology 2000, 141:2608-2613.
40. Coschigano K.T., Holland A.N., Riders M.E., List E.O., Flyvbjerg A., Kopchick J.J. Deletion, but not antagonism, of the mouse growth hormone receptor results in severely decreased body weights, insulin, and insulin-like growth factor I levels and increased life span. Endocrinology 2003, 144:3799-3810.
41. Cox L.S., Faragher R.G. From old organisms to new molecules: Integrative biology and therapeutic targets in accelerated human ageing. Cellular and Molecular Life Sciences 2007, 64:2620-2641.
42. Curtis J., de Cabo R. Utilizing calorie restriction to evaluate the role of sirtuins in healthspan and lifespan of mice. Methods in Molecular Biology 2013, 1077:303-311.
43. de Boer J., Andressoo J.O., de Wit J., Huijmans J., Beems R.B., van Steeg H., et al. Premature aging in mice deficient in DNA repair and transcription. Science 2002, 296:1276-1279.
44. De Luca G., Ventura I., Sanghez V., Russo M.T., Ajmone-Cat M.A., Cacci E., et al. Prolonged lifespan with enhanced exploratory behavior in mice overexpressing the oxidized nucleoside triphosphatase hMTH1. Aging Cell 2013, 12:695-705.
45. De Sandre-Giovannoli A., Bernard R., Cau P., Navarro C., Amiel J., Boccaccio I., et al. Lamin a truncation in Hutchinson-Gilford progeria. Science 2003, 300:2055.
46. Dechat T., Pfleghaar K., Sengupta K., Shimi T., Shumaker D.K., Solimando L., et al. Nuclear lamins: Major factors in the structural organization and function of the nucleus and chromatin. Genes & Development 2008, 22:832-853.
47. Dell'agnello C., Leo S., Agostino A., Szabadkai G., Tiveron C., Zulian A., et al. Increased longevity and refractoriness to Ca(2+)-dependent neurodegeneration in Surf1 knockout mice. Human Molecular Genetics 2007, 16:431-444.
48. Elchuri S., Oberley T.D., Qi W., Eisenstein R.S., Jackson Roberts L., Van Remmen H., et al. CuZnSOD deficiency leads to persistent and widespread oxidative damage and hepatocarcinogenesis later in life. Oncogene 2005, 24:367-380.
49. Enns L.C., Morton J.F., Treuting P.R., Emond M.J., Wolf N.S., Dai D.F., et al. Disruption of protein kinase A in mice enhances healthy aging. PLoS One 2009, 4:e5963.
50. Eriksson M., Brown W.T., Gordon L.B., Glynn M.W., Singer J., Scott L., et al. Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome. Nature 2003, 423:293-298.
51. Flurkey K., Papaconstantinou J., Harrison D.E. The Snell dwarf mutation Pit1(dw) can increase life span in mice. Mechanisms of Ageing and Development 2002, 123:121-130.
52. Flurkey K., Papaconstantinou J., Miller R.A., Harrison D.E. Lifespan extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:6736-6741.
53. Flynn J.M., O'Leary M.N., Zambataro C.A., Academia E.C., Presley M.P., Garrett B.J., et al. Late-life rapamycin treatment reverses age-related heart dysfunction. Aging Cell 2013, 12:851-862.
54. Fok W.C., Zhang Y., Salmon A.B., Bhattacharya A., Gunda R., Jones D., et al. Short-term treatment with rapamycin and dietary restriction have overlapping and distinctive effects in young mice. Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2013, 68:108-116.
55. Fontana L., Partridge L., Longo V.D. Extending healthy life span-From yeast to humans. Science 2010, 328:321-326.
56. Foukas L.C., Bilanges B., Bettedi L., Pearce W., Ali K., Sancho S., et al. Long-term p110alpha PI3K inactivation exerts a beneficial effect on metabolism. EMBO Molecular Medicine 2013, 5:563-571.
57. Foukas L.C., Claret M., Pearce W., Okkenhaug K., Meek S., Peskett E., et al. Critical role for the p110alpha phosphoinositide-3-OH kinase in growth and metabolic regulation. Nature 2006, 441:366-370.
58. Freitas A.A., de Magalhaes J.P. A review and appraisal of the DNA damage theory of ageing. Mutation Research 2011, 728:12-22.
59. Gates A.C., Bernal-Mizrachi C., Chinault S.L., Feng C., Schneider J.G., Coleman T., et al. Respiratory uncoupling in skeletal muscle delays death and diminishes age-related disease. Cell Metabolism 2007, 6:497-505.
60. Garcia-Cao I., Garcia-Cao M., Martin-Caballero J., Criado L.M., Klatt P., Flores J.M., et al. "Super p53" mice exhibit enhanced DNA damage response, are tumor resistant and age normally. The EMBO Journal 2002, 21:6225-6235.
61. Gems D., Partridge L. Genetics of longevity in model organisms: Debates and paradigm shifts. Annual Review of Physiology 2013, 75:621-644.
62. Gordon L.B., Kleinman M.E., Miller D.T., Neuberg D.S., Giobbie-Hurder A., Gerhard-Herman M., et al. Clinical trial of a farnesyltransferase inhibitor in children with Hutchinson-Gilford progeria syndrome. Proceedings of the National Academy of Sciences of the United States of America 2012, 109:16666-16671.
63. Guarente L. Calorie restriction and sirtuins revisited. Genes & Development 2013, 27:2072-2085.
64. Haigis M.C., Sinclair D.A. Mammalian sirtuins: Biological insights and disease relevance. Annual Review of Pathology 2010, 5:253-295.
65. Harper J.M., Wilkinson J.E., Miller R.A. Macrophage migration inhibitory factor-knockout mice are long lived and respond to caloric restriction. The FASEB Journal 2010, 24:2436-2442.
66. Harrison D.E., Strong R., Sharp Z.D., Nelson J.F., Astle C.M., Flurkey K., et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 2009, 460:392-395.
67. Hasty P., Campisi J., Hoeijmakers J., van Steeg H., Vijg J. Aging and genome maintenance: Lessons from the mouse?. Science 2003, 299:1355-1359.
68. Hasty P., Vijg J. Accelerating aging by mouse reverse genetics: A rational approach to understanding longevity. Aging Cell 2004, 3:55-65.
69. Hayden M.S., Ghosh S. Shared principles in NF-kappaB signaling. Cell 2008, 132:344-362.
70. Herranz D., Munoz-Martin M., Canamero M., Mulero F., Martinez-Pastor B., Fernandez-Capetillo O., et al. Sirt1 improves healthy ageing and protects from metabolic syndrome-associated cancer. Nature Communications 2010, 1:3.
71. Holzenberger M., Dupont J., Ducos B., Leneuve P., Geloen A., Even P.C., et al. IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature 2003, 421:182-187.
72. Hu D., Cao P., Thiels E., Chu C.T., Wu G.Y., Oury T.D., et al. Hippocampal long-term potentiation, memory, and longevity in mice that overexpress mitochondrial superoxide dismutase. Neurobiology of Learning and Memory 2007, 87:372-384.
73. Hubbard B.P., Gomes A.P., Dai H., Li J., Case A.W., Considine T., et al. Evidence for a common mechanism of SIRT1 regulation by allosteric activators. Science 2013, 339:1216-1219.
74. Hughes K.J., Kennedy B.K. Cell biology. Rapamycin paradox resolved. Science 2012, 335:1578-1579.
75. Ikeno Y., Bronson R.T., Hubbard G.B., Lee S., Bartke A. Delayed occurrence of fatal neoplastic diseases in ames dwarf mice: Correlation to extended longevity. Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2003, 58:291-296.
76. Ikeno Y., Hubbard G.B., Lee S., Cortez L.A., Lew C.M., Webb C.R., et al. Reduced incidence and delayed occurrence of fatal neoplastic diseases in growth hormone receptor/binding protein knockout mice. Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2009, 64:522-529.
77. Imai S., Armstrong C.M., Kaeberlein M., Guarente L. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 2000, 403:795-800.
78. Inagaki T., Lin V.Y., Goetz R., Mohammadi M., Mangelsdorf D.J., Kliewer S.A. Inhibition of growth hormone signaling by the fasting-induced hormone FGF21. Cell Metabolism 2008, 8:77-83.
79. Ingram D.K., Zhu M., Mamczarz J., Zou S., Lane M.A., Roth G.S., et al. Calorie restriction mimetics: An emerging research field. Aging Cell 2006, 5:97-108.
80. Jang Y.C., Perez V.I., Song W., Lustgarten M.S., Salmon A.B., Mele J., et al. Overexpression of Mn superoxide dismutase does not increase life span in mice. Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2009, 64:1114-1125.
81. Johnson S.C., Rabinovitch P.S., Kaeberlein M. mTOR is a key modulator of ageing and age-related disease. Nature 2013, 493:338-345.
82. Kanfi Y., Naiman S., Amir G., Peshti V., Zinman G., Nahum L., et al. The sirtuin SIRT6 regulates lifespan in male mice. Nature 2012, 483:218-221.
83. Kanfi Y., Peshti V., Gil R., Naiman S., Nahum L., Levin E., et al. SIRT6 protects against pathological damage caused by diet-induced obesity. Aging Cell 2010, 9:162-173.
84. Kappeler L., De Magalhaes Filho C., Dupont J., Leneuve P., Cervera P., Perin L., et al. Brain IGF-1 receptors control mammalian growth and lifespan through a neuroendocrine mechanism. PLoS Biology 2008, 6:e254.
85. Kawahara T.L., Michishita E., Adler A.S., Damian M., Berber E., Lin M., et al. SIRT6 links histone H3 lysine 9 deacetylation to NF-kappaB-dependent gene expression and organismal life span. Cell 2009, 136:62-74.
86. Kenyon C.J. The genetics of ageing. Nature 2010, 464:504-512.
87. Kipling D., Davis T., Ostler E.L., Faragher R.G. What can progeroid syndromes tell us about human aging?. Science 2004, 305:1426-1431.
88. Kipling D., Faragher R.G. Progeroid syndromes: Probing the molecular basis of aging?. Molecular Pathology 1997, 50:234-241.
89. Krishnan V., Chow M.Z., Wang Z., Zhang L., Liu B., Liu X., et al. Histone H4 lysine 16 hypoacetylation is associated with defective DNA repair and premature senescence in Zmpste24-deficient mice. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:12325-12330.
90. Kubicky R.A., Wu S., Kharitonenkov A., De Luca F. Role of fibroblast growth factor 21 (FGF21) in undernutrition-related attenuation of growth in mice. Endocrinology 2012, 153:2287-2295.
91. Kudlow B.A., Kennedy B.K., Monnat R.J. Werner and Hutchinson-Gilford progeria syndromes: Mechanistic basis of human progeroid diseases. Nature Reviews Molecular Cell Biology 2007, 8:394-404.
92. Kuro-o M., Matsumura Y., Aizawa H., Kawaguchi H., Suga T., Utsugi T., et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 1997, 390:45-51.
93. Kurosu H., Yamamoto M., Clark J.D., Pastor J.V., Nandi A., Gurnani P., et al. Suppression of aging in mice by the hormone Klotho. Science 2005, 309:1829-1833.
94. Kwan K.Y., Wang J.C. Mice lacking DNA topoisomerase IIIbeta develop to maturity but show a reduced mean lifespan. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:5717-5721.
95. Kwon J., Han E., Bui C.B., Shin W., Lee J., Lee S., et al. Assurance of mitochondrial integrity and mammalian longevity by the p62-Keap1-Nrf2-Nqo1 cascade. EMBO Reports 2012, 13:150-156.
96. Lamming D.W., Ye L., Katajisto P., Goncalves M.D., Saitoh M., Stevens D.M., et al. Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity. Science 2012, 335:1638-1643.
97. Laplante M., Sabatini D.M. mTOR signaling in growth control and disease. Cell 2012, 149:274-293.
98. Lapointe J., Stepanyan Z., Bigras E., Hekimi S. Reversal of the mitochondrial phenotype and slow development of oxidative biomarkers of aging in long-lived Mclk1+/- mice. The Journal of Biological Chemistry 2009, 284:20364-20374.
99. Lebel M., Lavoie J., Gaudreault I., Bronsard M., Drouin R. Genetic cooperation between the Werner syndrome protein and poly(ADP-ribose) polymerase-1 in preventing chromatid breaks, complex chromosomal rearrangements, and cancer in mice. The American Journal of Pathology 2003, 162:1559-1569.
100. Lebel M., Leder P. A deletion within the murine Werner syndrome helicase induces sensitivity to inhibitors of topoisomerase and loss of cellular proliferative capacity. Proceedings of the National Academy of Sciences of the United States of America 1998, 95:13097-13102.
101. Lebel M., Massip L., Garand C., Thorin E. Ascorbate improves metabolic abnormalities in Wrn mutant mice but not the free radical scavenger catechin. Annals of the New York Academy of Sciences 2010, 1197:40-44.
102. Li Y., Huang T.T., Carlson E.J., Melov S., Ursell P.C., Olson J.L., et al. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nature Genetics 1995, 11:376-381.
103. Li Q., Ren J. Influence of cardiac-specific overexpression of insulin-like growth factor 1 on lifespan and aging-associated changes in cardiac intracellular Ca2+ homeostasis, protein damage and apoptotic protein expression. Aging Cell 2007, 6:799-806.
104. Li Y., Xu W., McBurney M.W., Longo V.D. SirT1 inhibition reduces IGF-I/IRS-2/Ras/ERK1/2 signaling and protects neurons. Cell Metabolism 2008, 8:38-48.
105. Liang H., Masoro E.J., Nelson J.F., Strong R., McMahan C.A., Richardson A. Genetic mouse models of extended lifespan. Experimental Gerontology 2003, 38:1353-1364.
106. Liao C.Y., Kennedy B.K. Will the real aging Sirtuin please stand up?. Cell Research 2012, 22:1215-1217.
107. Liao C.Y., Rikke B.A., Johnson T.E., Diaz V., Nelson J.F. Genetic variation in the murine lifespan response to dietary restriction: From life extension to life shortening. Aging Cell 2010, 9:92-95.
108. Liu J.P., Baker J., Perkins A.S., Robertson E.J., Efstratiadis A. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 1993, 75:59-72.
109. Liu B., Ghosh S., Yang X., Zheng H., Liu X., Wang Z., et al. Resveratrol rescues SIRT1-dependent adult stem cell decline and alleviates progeroid features in laminopathy-based progeria. Cell Metabolism 2012, 16:738-750.
110. Liu X., Jiang N., Hughes B., Bigras E., Shoubridge E., Hekimi S. Evolutionary conservation of the clk-1-dependent mechanism of longevity: Loss of mclk1 increases cellular fitness and lifespan in mice. Genes & Development 2005, 19:2424-2434.
111. Liu B., Wang J., Chan K.M., Tjia W.M., Deng W., Guan X., et al. Genomic instability in laminopathy-based premature aging. Nature Medicine 2005, 11:780-785.
112. Liu B., Wang Z., Ghosh S., Zhou Z. Defective ATM-Kap-1-mediated chromatin remodeling impairs DNA repair and accelerates senescence in progeria mouse model. Aging Cell 2013, 12:316-318.
113. Lombard D.B., Beard C., Johnson B., Marciniak R.A., Dausman J., Bronson R., et al. Mutations in the WRN gene in mice accelerate mortality in a p53-null background. Molecular and Cellular Biology 2000, 20:3286-3291.
114. Lorenzini A., Salmon A.B., Lerner C., Torres C., Ikeno Y., Motch S., et al. Mice producing reduced levels of insulin-like growth factor type 1 display an increase in maximum, but not mean, life span. Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2013, 69:410-419.
115. Marino G., Ugalde A.P., Fernandez A.F., Osorio F.G., Fueyo A., Freije J.M., et al. Insulin-like growth factor 1 treatment extends longevity in a mouse model of human premature aging by restoring somatotroph axis function. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:16268-16273.
116. Marino G., Ugalde A.P., Salvador-Montoliu N., Varela I., Quiros P.M., Cadinanos J., et al. Premature aging in mice activates a systemic metabolic response involving autophagy induction. Human Molecular Genetics 2008, 17:2196-2211.
117. Martin-Montalvo A., Mercken E.M., Mitchell S.J., Palacios H.H., Mote P.L., Scheibye-Knudsen M., et al. Metformin improves healthspan and lifespan in mice. Nature Communications 2013, 4:2192.
118. Masoro E.J. Overview of caloric restriction and ageing. Mechanisms of Ageing and Development 2005, 126:913-922.
119. Massip L., Garand C., Turaga R.V., Deschenes F., Thorin E., Lebel M. Increased insulin, triglycerides, reactive oxygen species, and cardiac fibrosis in mice with a mutation in the helicase domain of the Werner syndrome gene homologue. Experimental Gerontology 2006, 41:157-168.
120. Mattison J.A., Roth G.S., Beasley T.M., Tilmont E.M., Handy A.M., Herbert R.L., et al. Impact of caloric restriction on health and survival in rhesus monkeys from the NIA study. Nature 2012, 489:318-321.
121. McCay C.M., Crowell M.F., Maynard L.A. The effect of retarded growth upon the length of life and upon the ultimate body size. Journal of Nutrition 1935, 10:63-79.
122. Mercken E.M., Hu J., Krzysik-Walker S., Wei M., Li Y., McBurney M.W., et al. SIRT1 but not its increased expression is essential for lifespan extension in caloric-restricted mice. Aging Cell 2014, 13:193-196.
123. Michishita E., McCord R.A., Berber E., Kioi M., Padilla-Nash H., Damian M., et al. SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin. Nature 2008, 452:492-496.
124. Migliaccio E., Giorgio M., Mele S., Pelicci G., Reboldi P., Pandolfi P.P., et al. The p66shc adaptor protein controls oxidative stress response and life span in mammals. Nature 1999, 402:309-313.
125. Miller R.A. 'Accelerated aging': A primrose path to insight?. Aging Cell 2004, 3:47-51.
126. Miller R.A., Harrison D.E., Astle C.M., Baur J.A., Boyd A.R., de Cabo R., et al. Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice. Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2011, 66:191-201.
127. Miskin R., Masos T. Transgenic mice overexpressing urokinase-type plasminogen activator in the brain exhibit reduced food consumption, body weight and size, and increased longevity. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 1997, 52:B118-B124.
128. Mitsui A., Hamuro J., Nakamura H., Kondo N., Hirabayashi Y., Ishizaki-Koizumi S., et al. Overexpression of human thioredoxin in transgenic mice controls oxidative stress and life span. Antioxidants & Redox Signaling 2002, 4:693-696.
129. Monnat R.J. Human RECQ helicases: Roles in DNA metabolism, mutagenesis and cancer biology. Seminars in Cancer Biology 2010, 20:329-339.
130. Moskovitz J., Bar-Noy S., Williams W.M., Requena J., Berlett B.S., Stadtman E.R. Methionine sulfoxide reductase (MsrA) is a regulator of antioxidant defense and lifespan in mammals. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:12920-12925.
131. Mostoslavsky R., Chua K.F., Lombard D.B., Pang W.W., Fischer M.R., Gellon L., et al. Genomic instability and aging-like phenotype in the absence of mammalian SIRT6. Cell 2006, 124:315-329.
132. Mounkes L.C., Kozlov S., Hernandez L., Sullivan T., Stewart C.L. A progeroid syndrome in mice is caused by defects in A-type lamins. Nature 2003, 423:298-301.
133. Navarro C.L., De Sandre-Giovannoli A., Bernard R., Boccaccio I., Boyer A., Genevieve D., et al. Lamin A and ZMPSTE24 (FACE-1) defects cause nuclear disorganization and identify restrictive dermopathy as a lethal neonatal laminopathy. Human Molecular Genetics 2004, 13:2493-2503.
134. Neff F., Flores-Dominguez D., Ryan D.P., Horsch M., Schroder S., Adler T., et al. Rapamycin extends murine lifespan but has limited effects on aging. The Journal of Clinical Investigation 2013, 123:3272-3291.
135. Neumann C.A., Krause D.S., Carman C.V., Das S., Dubey D.P., Abraham J.L., et al. Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression. Nature 2003, 424:561-565.
136. Niccoli T., Partridge L. Ageing as a risk factor for disease. Current Biology 2012, 22:R741-R752.
137. Niedernhofer L.J., Garinis G.A., Raams A., Lalai A.S., Robinson A.R., Appeldoorn E., et al. A new progeroid syndrome reveals that genotoxic stress suppresses the somatotroph axis. Nature 2006, 444:1038-1043.
138. Nojima A., Yamashita M., Yoshida Y., Shimizu I., Ichimiya H., Kamimura N., et al. Haploinsufficiency of akt1 prolongs the lifespan of mice. PLoS One 2013, 8:e69178.
139. Oh Y.S., Kim D.G., Kim G., Choi E.C., Kennedy B.K., Suh Y., et al. Downregulation of lamin A by tumor suppressor AIMP3/p18 leads to a progeroid phenotype in mice. Aging Cell 2010, 9:810-822.
140. Ortega-Molina A., Efeyan A., Lopez-Guadamillas E., Munoz-Martin M., Gomez-Lopez G., Canamero M., et al. Pten positively regulates brown adipose function, energy expenditure, and longevity. Cell Metabolism 2012, 15:382-394.
141. Osorio F.G., Barcena C., Soria-Valles C., Ramsay A.J., de Carlos F., Cobo J., et al. Nuclear lamina defects cause ATM-dependent NF-kappaB activation and link accelerated aging to a systemic inflammatory response. Genes & Development 2012, 26:2311-2324.
142. Osorio F.G., Navarro C.L., Cadinanos J., Lopez-Mejia I.C., Quiros P.M., Bartoli C., et al. Splicing-directed therapy in a new mouse model of human accelerated aging. Science Translational Medicine 2011, 3. 106ra107.
143. Pan D., Zhu Q., Conboy M.J., Conboy I.M., Luo K. SnoN activates p53 directly to regulate aging and tumorigenesis. Aging Cell 2012, 11:902-911.
144. Panici J.A., Harper J.M., Miller R.A., Bartke A., Spong A., Masternak M.M. Early life growth hormone treatment shortens longevity and decreases cellular stress resistance in long-lived mutant mice. FASEB Journal 2010, 24:5073-5079.
145. Park S.G., Choi E.C., Kim S. Aminoacyl-tRNA synthetase-interacting multifunctional proteins (AIMPs): A triad for cellular homeostasis. IUBMB Life 2010, 62:296-302.
146. Park B.J., Oh Y.S., Park S.Y., Choi S.J., Rudolph C., Schlegelberger B., et al. AIMP3 haploinsufficiency disrupts oncogene-induced p53 activation and genomic stability. Cancer Research 2006, 66:6913-6918.
147. Pendas A.M., Zhou Z., Cadinanos J., Freije J.M., Wang J., Hultenby K., et al. Defective prelamin A processing and muscular and adipocyte alterations in Zmpste24 metalloproteinase-deficient mice. Nature Genetics 2002, 31:94-99.
148. Perez V.I., Bokov A., Van Remmen H., Mele J., Ran Q., Ikeno Y., et al. Is the oxidative stress theory of aging dead?. Biochimica et Biophysica Acta 2009, 1790:1005-1014.
149. Perez V.I., Cortez L.A., Lew C.M., Rodriguez M., Webb C.R., Van Remmen H., et al. Thioredoxin 1 overexpression extends mainly the earlier part of life span in mice. Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2011, 66:1286-1299.
150. Perez V.I., Van Remmen H., Bokov A., Epstein C.J., Vijg J., Richardson A. The overexpression of major antioxidant enzymes does not extend the lifespan of mice. Aging Cell 2009, 8:73-75.
151. Pyo J.O., Yoo S.M., Ahn H.H., Nah J., Hong S.H., Kam T.I., et al. Overexpression of Atg5 in mice activates autophagy and extends lifespan. Nature Communications 2013, 4:2300.
152. Ramos F.J., Chen S.C., Garelick M.G., Dai D.F., Liao C.Y., Schreiber K.H., et al. Rapamycin reverses elevated mTORC1 signaling in lamin A/C-deficient mice, rescues cardiac and skeletal muscle function, and extends survival. Science Translational Medicine 2012, 4:144ra103.
153. Ran Q., Liang H., Ikeno Y., Qi W., Prolla T.A., Roberts L.J., et al. Reduction in glutathione peroxidase 4 increases life span through increased sensitivity to apoptosis. Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2007, 62:932-942.
154. Redmann S.M., Argyropoulos G. AgRP-deficiency could lead to increased lifespan. Biochemical and Biophysical Research Communications 2006, 351:860-864.
155. Rossi M.L., Ghosh A.K., Bohr V.A. Roles of Werner syndrome protein in protection of genome integrity. DNA Repair (Amst) 2010, 9:331-344.
156. Rudolph K.L., Chang S., Lee H.W., Blasco M., Gottlieb G.J., Greider C., et al. Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell 1999, 96:701-712.
157. Salmon A.B., Perez V.I., Bokov A., Jernigan A., Kim G., Zhao H., et al. Lack of methionine sulfoxide reductase A in mice increases sensitivity to oxidative stress but does not diminish life span. FASEB Journal 2009, 23:3601-3608.
158. Satoh A., Brace C.S., Rensing N., Cliften P., Wozniak D.F., Herzog E.D., et al. Sirt1 extends life span and delays aging in mice through the regulation of Nk2 homeobox 1 in the DMH and LH. Cell Metabolism 2013, 18:416-430.
159. Scaffidi P., Misteli T. Lamin A-dependent nuclear defects in human aging. Science 2006, 312:1059-1063.
160. Schleit J., Johnson S.C., Bennett C.F., Simko M., Trongtham N., Castanza A., et al. Molecular mechanisms underlying genotype-dependent responses to dietary restriction. Aging Cell 2013, 12:1050-1061.
161. Schreiber K.H., Kennedy B.K. When lamins go bad: Nuclear structure and disease. Cell 2013, 152:1365-1375.
162. Schriner S.E., Linford N.J., Martin G.M., Treuting P., Ogburn C.E., Emond M., et al. Extension of murine life span by overexpression of catalase targeted to mitochondria. Science 2005, 308:1909-1911.
163. Schumacher B., Hoeijmakers J.H., Garinis G.A. Sealing the gap between nuclear DNA damage and longevity. Molecular and Cellular Endocrinology 2009, 299:112-117.
164. Selman C., Lingard S., Choudhury A.I., Batterham R.L., Claret M., Clements M., et al. Evidence for lifespan extension and delayed age-related biomarkers in insulin receptor substrate 1 null mice. FASEB Journal 2008, 22:807-818.
165. Selman C., Lingard S., Gems D., Partridge L., Withers D.J. Comment on "brain IRS2 signaling coordinates life span and nutrient homeostasis". Science 2008, 320:1012. author reply 1012.
166. Selman C., Partridge L., Withers D.J. Replication of extended lifespan phenotype in mice with deletion of insulin receptor substrate 1. PLoS One 2011, 6:e16144.
167. Selman C., Tullet J.M., Wieser D., Irvine E., Lingard S.J., Choudhury A.I., et al. Ribosomal protein S6 kinase 1 signaling regulates mammalian life span. Science 2009, 326:140-144.
168. Selman C., Withers D.J. Mammalian models of extended healthy lifespan. Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences 2011, 366:99-107.
169. Singh S.P., Niemczyk M., Saini D., Sadovov V., Zimniak L., Zimniak P. Disruption of the mGsta4 gene increases life span of C57BL mice. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 2010, 65:14-23.
170. Sohal R.S., Weindruch R. Oxidative stress, caloric restriction, and aging. Science 1996, 273:59-63.
171. Stewart C.L., Kozlov S., Fong L.G., Young S.G. Mouse models of the laminopathies. Experimental Cell Research 2007, 313:2144-2156.
172. Streeper R.S., Grueter C.A., Salomonis N., Cases S., Levin M.C., Koliwad S.K., et al. Deficiency of the lipid synthesis enzyme, DGAT1, extends longevity in mice. Aging (Albany NY) 2012, 4:13-27.
173. Sullivan T., Escalante-Alcalde D., Bhatt H., Anver M., Bhat N., Nagashima K., et al. Loss of A-type lamin expression compromises nuclear envelope integrity leading to muscular dystrophy. The Journal of Cell Biology 1999, 147:913-920.
174. Sun L.Y., Spong A., Swindell W.R., Fang Y., Hill C., Huber J.A., et al. Growth hormone-releasing hormone disruption extends lifespan and regulates response to caloric restriction in mice. eLife 2013, 2:e01098.
175. Taguchi A., Wartschow L.M., White M.F. Brain IRS2 signaling coordinates life span and nutrient homeostasis. Science 2007, 317:369-372.
176. Tanny J.C., Dowd G.J., Huang J., Hilz H., Moazed D. An enzymatic activity in the yeast Sir2 protein that is essential for gene silencing. Cell 1999, 99:735-745.
177. Tennen R.I., Chua K.F. Chromatin regulation and genome maintenance by mammalian SIRT6. Trends in Biochemical Sciences 2011, 36:39-46.
178. Tilstra J.S., Clauson C.L., Niedernhofer L.J., Robbins P.D. NF-kappaB in aging and disease. Aging and Disease 2011, 2:449-465.
179. Tilstra J.S., Robinson A.R., Wang J., Gregg S.Q., Clauson C.L., Reay D.P., et al. NF-kappaB inhibition delays DNA damage-induced senescence and aging in mice. The Journal of Clinical Investigation 2012, 122:2601-2612.
180. Tomas-Loba A., Flores I., Fernandez-Marcos P.J., Cayuela M.L., Maraver A., Tejera A., et al. Telomerase reverse transcriptase delays aging in cancer-resistant mice. Cell 2008, 135:609-622.
181. Trifunovic A., Wredenberg A., Falkenberg M., Spelbrink J.N., Rovio A.T., Bruder C.E., et al. Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature 2004, 429:417-423.
182. Tyner S.D., Venkatachalam S., Choi J., Jones S., Ghebranious N., Igelmann H., et al. p53 mutant mice that display early ageing-associated phenotypes. Nature 2002, 415:45-53.
183. Valko M., Rhodes C.J., Moncol J., Izakovic M., Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chemico-Biological Interactions 2006, 160:1-40.
184. van der Pluijm I., Garinis G.A., Brandt R.M., Gorgels T.G., Wijnhoven S.W., Diderich K.E., et al. Impaired genome maintenance suppresses the growth hormone-insulin-like growth factor 1 axis in mice with Cockayne syndrome. PLoS Biology 2007, 5:e2.
185. Van Remmen H., Ikeno Y., Hamilton M., Pahlavani M., Wolf N., Thorpe S.R., et al. Life-long reduction in MnSOD activity results in increased DNA damage and higher incidence of cancer but does not accelerate aging. Physiological Genomics 2003, 16:29-37.
186. Varela I., Cadinanos J., Pendas A.M., Gutierrez-Fernandez A., Folgueras A.R., Sanchez L.M., et al. Accelerated ageing in mice deficient in Zmpste24 protease is linked to p53 signalling activation. Nature 2005, 437:564-568.
187. Vogel H., Lim D.S., Karsenty G., Finegold M., Hasty P. Deletion of Ku86 causes early onset of senescence in mice. Proceedings of the National Academy of Sciences of the United States of America 1999, 96:10770-10775.
188. Wang L., Ogburn C.E., Ware C.B., Ladiges W.C., Youssoufian H., Martin G.M., et al. Cellular Werner phenotypes in mice expressing a putative dominant-negative human WRN gene. Genetics 2000, 154:357-362.
189. Weindruch R., Walford L.R. The retardation of aging and disease by dietary restriction 1988, Charles C Thomas Publisher, Springfield, III.
190. Wilkinson J.E., Burmeister L., Brooks S.V., Chan C.C., Friedline S., Harrison D.E., et al. Rapamycin slows aging in mice. Aging Cell 2012, 11:675-682.
191. Wong K.K., Maser R.S., Bachoo R.M., Menon J., Carrasco D.R., Gu Y., et al. Telomere dysfunction and Atm deficiency compromises organ homeostasis and accelerates ageing. Nature 2003, 421:643-648.
192. Wolf E., Kahnt E., Ehrlein J., Hermanns W., Brem G., Wanke R. Effects of long-term elevated serum levels of growth hormone on life expectancy of mice: Lessons from transgenic animal models. Mechanisms of Ageing and Development 1993, 68:71-87.
193. Wu J.J., Liu J., Chen E.B., Wang J.J., Cao L., Narayan N., et al. Increased mammalian lifespan and a segmental and tissue-specific slowing of aging after genetic reduction of mTOR expression. Cell Reports 2013, 4:913-920.
194. Xu J., Gontier G., Chaker Z., Lacube P., Dupont J., Holzenberger M. Longevity effect of IGF-1R(+/-) mutation depends on genetic background-specific receptor activation. Aging Cell 2013, 13:19-28.
195. Yan L., Vatner D.E., O'Connor J.P., Ivessa A., Ge H., Chen W., et al. Type 5 adenylyl cyclase disruption increases longevity and protects against stress. Cell 2007, 130:247-258.
196. Yang X., Doser T.A., Fang C.X., Nunn J.M., Janardhanan R., Zhu M., et al. Metallothionein prolongs survival and antagonizes senescence-associated cardiomyocyte diastolic dysfunction: role of oxidative stress. The FASEB Journal 2006, 20:1024-1026.
197. Yuan R., Peters L.L., Paigen B. Mice as a mammalian model for research on the genetics of aging. ILAR Journal/National Research Council, Institute of Laboratory Animal Resources 2011, 52:4-15.
198. Yuan R., Tsaih S.W., Petkova S.B., Marin de Evsikova C., Xing S., Marion M.A., et al. Aging in inbred strains of mice: Study design and interim report on median lifespans and circulating IGF1 levels. Aging Cell 2009, 8:277-287.
199. Zhang Y., Bokov A., Gelfond J., Soto V., Ikeno Y., Hubbard G., et al. Rapamycin extends life and health in C57BL/6 mice. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 2014, 69:119-130.
200. Zhang Y., Ikeno Y., Qi W., Chaudhuri A., Li Y., Bokov A., et al. Mice deficient in both Mn superoxide dismutase and glutathione peroxidase-1 have increased oxidative damage and a greater incidence of pathology but no reduction in longevity. Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2009, 64:1212-1220.
201. Zhang H., Kieckhaefer J.E., Cao K. Mouse models of laminopathies. Aging Cell 2013, 12:2-10.
202. Zhang G., Li J., Purkayastha S., Tang Y., Zhang H., Yin Y., et al. Hypothalamic programming of systemic ageing involving IKK-beta, NF-kappaB and GnRH. Nature 2013, 497:211-216.
203. Zhang Y., Xie Y., Berglund E.D., Coate K.C., He T.T., Katafuchi T., et al. The starvation hormone, fibroblast growth factor-21, extends lifespan in mice. eLife 2012, 1:e00065.
204. Zhou G., Myers R., Li Y., Chen Y., Shen X., Fenyk-Melody J., et al. Role of AMP-activated protein kinase in mechanism of metformin action. The Journal of Clinical Investigation 2001, 108:1167-1174.
205. Zid B.M., Rogers A.N., Katewa S.D., Vargas M.A., Kolipinski M.C., Lu T.A., et al. 4E-BP extends lifespan upon dietary restriction by enhancing mitochondrial activity in Drosophila. Cell 2009, 139:149-160.